Tianjin Medical University General Hospital
🇨🇳China
The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors
Phase 1
Recruiting
- Conditions
- Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)AML (Acute Myelogenous Leukemia)B-ALLMyeloma MultipleT-lymphocyte LymphomaT-ALL/Lymphoma
- Interventions
- Drug: CAR-T Cells infusion（CAR2219,CAR2019, CAR19 etc）
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT06911710
- Locations
- 🇨🇳
TianJin China. TianJin Medical University General, TianJin, Tianjin, China
Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes
Not Applicable
Recruiting
- Conditions
- Monogenic Diabetes
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT06746610
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, China
Eculizumab for Acute Attack of Neuromyelitis Optica Spectrum Disorder
Phase 2
Not yet recruiting
- Conditions
- Neuromyelitis Optica Spectrum Disorder Attack
- Interventions
- Drug: IVMPDrug: Complement protein C5 inhibitor
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT06673394
Identify the State of Laminae Milling by Sound
Completed
- Conditions
- Spinal Degenerative Diseases
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 6
- Registration Number
- NCT06665360
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum Disorder
Phase 1
Not yet recruiting
- Conditions
- Neuromyelitis Optica Spectrum Disorder
- Interventions
- Drug: Anti-BAFFR CART
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06561009
Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury
Phase 1
Recruiting
- Conditions
- Pulmonary Injury After Intracerebral Hemorrhage
- Interventions
- First Posted Date
- 2024-08-12
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06548802
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack
Phase 2
Not yet recruiting
- Conditions
- NMO Spectrum DisorderNeuromyelitis Optica Spectrum DisorderNeuromyelitis Optica
- Interventions
- First Posted Date
- 2024-07-11
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 63
- Registration Number
- NCT06497374
Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Phase 2
Recruiting
- Conditions
- Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
- Interventions
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 102
- Registration Number
- NCT06452537
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
The Effect of Esketamine on Sleep Disturbance
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 204
- Registration Number
- NCT06388824
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, China
Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06327451
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, China
© Copyright 2025. All Rights Reserved by MedPath